Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H8NOS.Au |
| Molecular Weight | 363.187 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Au+].[S-]CC(=O)NC1=CC=CC=C1
InChI
InChIKey=ODENGJOFMCVWCT-UHFFFAOYSA-M
InChI=1S/C8H9NOS.Au/c10-8(6-11)9-7-4-2-1-3-5-7;/h1-5,11H,6H2,(H,9,10);/q;+1/p-1
| Molecular Formula | Au |
| Molecular Weight | 196.966569 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C8H9NOS |
| Molecular Weight | 167.228 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
100 mg 1 times / week steady, intramuscular Dose: 100 mg, 1 times / week Route: intramuscular Route: steady Dose: 100 mg, 1 times / week Sources: |
unhealthy, 52 years (range: 18-72 years) Health Status: unhealthy Age Group: 52 years (range: 18-72 years) Sex: M+F Sources: |
Disc. AE: Thrombocytopenic purpura... AEs leading to discontinuation/dose reduction: Thrombocytopenic purpura (1 patient) Sources: |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Thrombocytopenic purpura | 1 patient Disc. AE |
100 mg 1 times / week steady, intramuscular Dose: 100 mg, 1 times / week Route: intramuscular Route: steady Dose: 100 mg, 1 times / week Sources: |
unhealthy, 52 years (range: 18-72 years) Health Status: unhealthy Age Group: 52 years (range: 18-72 years) Sex: M+F Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Treatment of rheumatoid arthritis with aurothioglycanide (lauron) | 1953-07-11 |
|
| Clinical evaluation of aurothioglycolanilide (Lauron-Endo) in rheumatoid arthritis. | 1951-08 |
|
| Lauron in rheumatoid arthritis; a further report. | 1946-08 |
|
| LAURON IN RHEUMATOID ARTHRITIS: (A further report). | 1946-08 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:56:05 GMT 2025
by
admin
on
Mon Mar 31 17:56:05 GMT 2025
|
| Record UNII |
2A9D34A16M
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
10381
Created by
admin on Mon Mar 31 17:56:05 GMT 2025 , Edited by admin on Mon Mar 31 17:56:05 GMT 2025
|
PRIMARY | |||
|
100000086640
Created by
admin on Mon Mar 31 17:56:05 GMT 2025 , Edited by admin on Mon Mar 31 17:56:05 GMT 2025
|
PRIMARY | |||
|
186
Created by
admin on Mon Mar 31 17:56:05 GMT 2025 , Edited by admin on Mon Mar 31 17:56:05 GMT 2025
|
PRIMARY | |||
|
C166562
Created by
admin on Mon Mar 31 17:56:05 GMT 2025 , Edited by admin on Mon Mar 31 17:56:05 GMT 2025
|
PRIMARY | |||
|
2A9D34A16M
Created by
admin on Mon Mar 31 17:56:05 GMT 2025 , Edited by admin on Mon Mar 31 17:56:05 GMT 2025
|
PRIMARY | |||
|
16925-51-2
Created by
admin on Mon Mar 31 17:56:05 GMT 2025 , Edited by admin on Mon Mar 31 17:56:05 GMT 2025
|
PRIMARY | |||
|
m57
Created by
admin on Mon Mar 31 17:56:05 GMT 2025 , Edited by admin on Mon Mar 31 17:56:05 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID10168680
Created by
admin on Mon Mar 31 17:56:05 GMT 2025 , Edited by admin on Mon Mar 31 17:56:05 GMT 2025
|
PRIMARY | |||
|
SUB05611MIG
Created by
admin on Mon Mar 31 17:56:05 GMT 2025 , Edited by admin on Mon Mar 31 17:56:05 GMT 2025
|
PRIMARY |